Why it was recalled
Failed stability specifications
Product description
Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-865-60
Lot numbers, UPCs & expiration codes
Lot # H210233, Exp 3/1/2023
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0577-2022
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Jan 19, 2022
- FDA report date
- Mar 2, 2022
- Quantity
- 2,980 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
Original FDA data
Every field from FDA enforcement report D-0577-2022, exactly as published.
Show all FDA fields
- City
- Princeton
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 89447
- Address
- 107 College Rd E
- Code information
- Lot # H210233, Exp 3/1/2023
- Postal code
- 08540-6623
- Report date
- Mar 2, 2022
- Product type
- Drugs
- Recall number
- D-0577-2022
- Classification
- Class III
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Product quantity
- 2,980 vials
- Termination date
- Dec 13, 2022
- Reason for recall
- Failed stability specifications
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-865-60
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Jan 19, 2022
- Initial firm notification
- Letter
- Center classification date
- Feb 22, 2022